English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/149713
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Drugs on clinical development for the treatment of amyotrophic lateral sclerosis

AutorMartínez, Ana ; Palomo Ruiz, Valle; Pérez, Daniel I.; Gil, Carmen
Palabras claveALS
New drugs
Clinical trials
Cell therapy
Biomarkers
Fecha de publicaciónabr-2017
EditorTaylor & Francis
CitaciónExpert Opin Investig Drugs. 26(4):403-414 (2017)
ResumenIntroduction: Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron progressive disorder for which no treatment exists up to date. However, there are some investigational drugs and therapies under clinical development that may offer some hope in the near future
Areas covered: We have revised all the ALS ongoing clinical trials (until November 2016) and collected in Clinical.trials.gov or EudraCT. We have described them in a comprehensive way and grouped them in the following sections: biomarkers, biological therapies, cell therapy, drug repurposing and new drugs.
Expert Opinion: Despite the multiple obstacles that explain the absence of effective drugs for the treatment of ALS, joint efforts among patient’s associations, public and private sectors have fueled innovative research in the field, resulting in several compounds that are in the late stages of clinical trials. Drug repositioning is also playing an important role, having achieved the approval of some orphan drug applications, in late phases of clinical development. Endaravone has been recently approved in Japan and is pending in USA.
Descripción30 p.-3 fig.-3 tab.
Versión del editorhttp://dx.doi.org/10.1080/13543784.2017.1302426
URIhttp://hdl.handle.net/10261/149713
DOI10.1080/13543784.2017.1302426
ISSN1354-3784
E-ISSN1744-7658
Aparece en las colecciones: (CIB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
EOID_Postprint_2017.pdfPostprint212,94 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.